HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Triclosan Concern In Congress Spurs Call For Final Antimicrobial Monograph

This article was originally published in The Rose Sheet

Executive Summary

Concern about the safety of triclosan has Rep. Ed Markey pressuring FDA to finalize the OTC Topical Antimicrobial Drug monograph, first proposed in 1972
Advertisement

Related Content

House Democrats Urge FDA To Ban Triclosan In Personal Care
Colgate Answers Markey With Study Backing Triclosan Benefit In Toothpaste
Rep. Markey Calls For Triclosan Ban, Galvanized By Sympathetic FDA Letter
CIR Panel's Priorities For 2010 Include Triclosan, Amino Acids, Talc
Environmental Group Opposes FDA Addition Of Triclosan To OTC Monographs
CIR Expert Panel Questions Skin Whitener Kojic Acid
Preservative Triclosan Not Safe In Leave-On Products, Mouthwashes – SCCP
Antibiotics, Not Antimicrobials, To Blame For Resistant Bacteria – SDA
SDA Calls For “Reasoned Discussions” On Triclocarban Research
FDA Should Ban Non-Medical Triclosan Products – Citizen Petition
Advertisement
UsernamePublicRestriction

Register

RS016661

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel